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Brief Clinical ReportsLate complete atrioventricular block and tricuspid regurgitation
after percutaneous closure of a perimembranous ventricular
septal defectHuiwen Chen, MD, Jinfen Liu, MD, Wei Gao, MD, and Haifa Hong, MD, Shanghai, ChinaPercutaneous closure of a perimembranous ventricular
septal defect (VSD) is nowadays a valuable alternative to
surgical closure. Preliminary results regarding the safety of
this device and the low incidence of aortic and tricuspid re-
gurgitation are encouraging.1,2 However, owing to the close
proximity of the perimembranous VSD to the conduction
system, concern about atrioventricular block has been
raised. The published reports3 on this complication describe
the latest onset of complete atrioventricular block (CAVB),
presenting at 37.8 months after implantation. We report here
1 case of delayed CAVB with severe tricuspid regurgitation
occurring 5 years after implantation of an eccentric Amplat-
zer perimembranous VSD occluder (APmVSDO; AGA
Medical, Golden Valley, Minn).FIGURE 1. Amplatzer perimembranous ventricular septal defect occluder
(APmVSDO) (blue arrow) was visible transatrially, the tricuspid septal
valve (green arrow) was pushed down the septum totally, and the chordae
tendineae (white arrow) attached to the septal and posterior valves were
twisted with the APmVSDO.CLINICAL SUMMARY
A 71/2-year-old, 19-kg boy was referred to our center for
CAVB. His percutaneous procedure had been performed at 2
years 8 months in another institute. An 8-mm device was
used. At presentation, he was vomiting and pale with a heart
rate of 50 beats/min. An echocardiogram demonstrated
severe tricuspid regurgitation. The ejection fraction was 64%
and the fractional shorteningwas 34%. Surgerywas inevitable
and performed by standard techniques of cardiopulmonary by-
pass, mild hypothermia, and cold blood antegrade cardiople-
gia. The APmVSDO was still visible transatrially (Figure 1).
The tricuspid septal valve was pushed down the septum totally
(Figure 1). The chordae tendineae attached to the septal and
posterior valves were twisted with the APmVSDO (Figure 1).
TheAPmVSDOwas peeled off the edge of the VSDwith scis-
sors (Figure 2). The VSD (Figure 3) was 10 mm and closed
continuouslywith autopericardium.The twisted chordae tendi-
neae were refixed. The commissure of the septal and posterior
valve was sutured with 2 interrupted 5–0 polypropylene su-
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e60 The Journal of Thoracic and Cardiovascular Surgrate of 50 to 60 beats/min. Transesophageal echocardiography
showed no residual shunt and trivial tricuspid regurgitation.
Theheart ratewas 50 to60 beats/min after 2weeks’monitoring
in the hospital. He underwent pacemaker implantation. An
echocardiogram performed at discharge showed trivial tricus-
pid regurgitation, an ejection fraction of 72%, and a fractional
shortening of 41%. Outpatient follow-up was advised with an
electrocardiogram and echocardiogram at 1 week, 1 month, 6
months, 1 year, and then yearly.DISCUSSION
Preliminary results of transcatheter closure of perimem-
branous VSD by an APmVSDO are encouraging, with no
mortality, high short-term technical success, and high
occlusion rates in the absence of any major concerns.3
The only serious concern is the occurrence of CAVB.
Butera and colleagues4 report longer term follow-up in
104 patients at a median of 38.5 months. The incidence ofery c September 2010
FIGURE 2. The Amplatzer perimembranous ventricular septal defect
occluder (APmVSDO) (blue arrow) was peeled off the edge of ventricular
septal defect with scissors.
FIGURE 3. The ventricular septal defect (red arrow) after removal of the
Amplatzer perimembranous ventricular septal defect occluder (APmVSDO).
Brief Clinical Reportscomplete heart block was 8.7%, and a permanent pacemaker
was required in 6 (5.7%) patients, 2 in the early phase and
4 during late follow-up. Predescu and coworkers3 reported
that 4 (22%) had complete heart block at 17 days, 4.2
months, 8.8 months, and 37.8 months after implantation,
respectively. On the basis of these data, implantation of
the perimembranous VSD device was terminated at Predes-
cu’s institution (the Hospital for Sick Children, Toronto,
Ontario, Canada). To our knowledge, this is the first study
reporting the latest occurrence of CAVB with severe tricus-
pid regurgitation in patients treated percutaneously for
a perimembranous VSD.
It is possible that the right ventricular disc impinging on
the septal and posterior leaflet and the device shift may cause
it to disturb atrioventricular conduction by direct traumatic
compression. Atrioventricular conduction tissue trauma
and tricuspid regurgitation led to a vicious circle of further
trouble. Increased tricuspid regurgitation may be a risk fac-
tor of CAVB during short- and medium-term follow-up.
Surgical intervention for isolated perimembranous VSD
in experienced centers has achieved this with minimal mor-
tality and a very low incidence of CAVB.The Journal of Thoracic and CaTucker and associates5 reported that the incidence of
permanent pacemaker implantation was 0.4% and hospital
mortality was 0.2% in the contemporary era of 1315 patients
undergoing repair. Patients and their parents should be
informed to make a choice between the morbidity of cardio-
pulmonary bypass and the risk of sudden, potentially life-
threatening late-onset CAVB.References
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